1. Baroldi G, Camerini F, Goodwin JF. Advances in Cardiomyopathies. Berlin: Springer-Verlag; 1990:7–175.
2. Bassan M, Ganz W, Marcus HS, Swan HJC. The effect of in-tracoronary injection of contrast medium upon coronary blood flow. Circulation. 1975;51:442–445.
3. Camici PG, Cecchi F, Gistri R, et al. Dipyridamole-induced subendocardial underperfusion in hypertrophic cardiomyopathy assessed by positron emission tomography. Coron Artery Dis. 1991;2:837–841.
4. Camici PG, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired both in hypertrophied and nonhy-pertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with 13N-ammonia and positron emission tomography. J Am Coll Cardiol. 1991;17:879–886.
5. Camici PG, Marraccini P, Gistri R, Salvadori PA, Sorace O, L’Abbate A. Adrenergically-mediated coronary vasodilation in patients with syndrome X. Cardiovasc Drugs Ther. 1994;8:221–226.